MatTek

MatTek is a long-established, US-based innovator in human-relevant in vitro testing solutions. The company's core technology involves engineering physiologically relevant 3D human tissue models that serve as superior alternatives to animal testing for toxicology, efficacy, and basic research across pharmaceuticals, cosmetics, and consumer products. Recently acquired by the life science tools giant Sartorius, MatTek is positioned to scale its platform and services globally, leveraging a comprehensive suite of products that includes tissue models, primary cells, cultureware, and advanced histological/image analysis services.

Proprietary 3D human tissue engineering platform producing lab-grown, metabolically active epithelial tissue models (e.g., skin, cornea, airway, intestine). Supported by a bank of primary human cells, specialized cultureware, and advanced imaging/analysis services (Visikol). Includes micro-liver co-culture systems (HUREL) for ADME-tox.

MatTek competes with other 3D tissue model specialists like Epithelix and in specific organ-on-a-chip segments with companies like Emulate and Mimetas. It also faces competition from large life science tool suppliers (e.g., Corning, Thermo Fisher) offering cell culture products and basic assays. Its differentiation lies in its breadth of validated tissue models, primary cell expertise, and integrated histology/image analysis services.